The FDA approved the denosumab biosimilar Ospomyv, interchangeable with Prolia, for preventing osteoporosis-related fracture ...

While the FDA’s diversity guidance for clinical trials has been temporarily restored, the page it is housed on now carries a ...

A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...

FDA published a final version of its guidance document, “Communications From Firms to Health Care Providers Regarding ...

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

While a pause on federal health agencies is nothing new during presidential transitions, the Trump Administration’s ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

The anesthetic ketamine is being hailed as a breakthrough therapy for people with post-traumatic stress disorder (PTSD), treatment-resistant depression and other mood disorders.

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

Prominent health care organizations urge the Trump administration to restore important data sets on the Centers for Disease ...

Scott Gottlieb supports a reversion to an earlier interpretation of the 21st Century Cures Act, which would exempt more types ...